XML 32 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1Close
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flow from operating activities:    
Net income $ 977.0 $ 980.9
Adjustments to reconcile net income to net cash flow from operating activities:    
Depreciation and amortization 306.4 229.7
Excess and obsolescence charges related to inventory 44.4 36.8
Amortization of acquired inventory step-up 134.2 0.0
Share-based compensation 143.4 147.1
Deferred income taxes (47.1) (170.9)
(Gain) loss on strategic investments 61.6 (26.8)
Gain on sale of priority review voucher, net 88.6 0.0
Other 65.0 60.5
Changes in operating assets and liabilities, net of effects of business acquired:    
Inventory (188.2) (65.1)
Accrued expense and other current liabilities (115.6) (127.1)
Income tax assets and liabilities (7.7) (82.4)
Other changes in operating assets and liabilities, net (103.0) (55.5)
Net cash flow provided by (used in) operating activities 1,179.0 942.3 Close
Cash flow from investing activities:    
Purchases of property, plant and equipment (79.4) (137.6)
Proceeds from sales and maturities of marketable securities 0.0 1,682.2
Purchases of marketable securities 0.0 (4,120.3)
Proceeds from sale of equity interest in Samsung Bioepis 406.8 788.1
Proceeds from sale of priority review voucher 103.0 0.0
Acquisitions of intangible assets (84.1) (21.0)
Proceeds from sales of strategic investments 57.5 103.2
Other (3.3) (1.1)
Net cash flow provided by (used in) investing activities 400.5 (1,706.5) Close
Cash flow from financing activities:    
Payments related to issuance of stock for share-based compensation arrangements, net (40.8) (54.6)
Repayment of borrowings 650.0 0.0
Net (distribution) contribution to noncontrolling interest 0.0 1.7
Other 6.0 (0.3)
Net cash flow provided by (used in) financing activities (684.8) (53.2) Close
Net increase (decrease) in cash and cash equivalents 894.7 (817.4) Close
Effect of exchange rate changes on cash and cash equivalents (35.7) 15.9
Cash and cash equivalents, beginning of the period 1,049.9 3,419.3
Cash and cash equivalents, end of the period 1,908.9 2,617.8
Nonrelated Party    
Changes in operating assets and liabilities, net of effects of business acquired:    
Accounts receivable 12.3 21.8
Related Party    
Changes in operating assets and liabilities, net of effects of business acquired:    
Accounts receivable $ (15.1) $ (6.7)